Emerging Therapies and Future Outlook in Parkinson’s Disease

This section highlights the growing momentum in Parkinson’s disease research, particularly the development of disease-modifying therapies currently under investigation. The speaker discusses several promising approaches, including the REGENERATE-PD study evaluating gene therapy that delivers glial cell line-derived neurotrophic factor (GDNF) via a viral vector to support neuronal survival and potentially reduce medication needs. Another emerging strategy is the use of dopaminergic stem cell transplantation in the ExPDite-2 study, which aims to restore dopamine-producing neurons and improve motor function. Additional research areas include antibody therapies targeting alpha-synuclein, treatments for cognitive impairment and dementia with Lewy bodies, and new dopamine agonists in early clinical trials. Overall, the discussion emphasizes the rapidly expanding therapeutic landscape in Parkinson’s disease and the growing optimism that these innovations may improve symptom control, slow disease progression, and enhance patients’ quality of life.